Adial Pharmaceuticals, Inc.
ADIL
$0.33
$0.013.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.79M | -1.96M | -2.23M | -2.07M | -2.19M |
| Total Depreciation and Amortization | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 224.30K | 222.80K | 249.80K | 364.00K | 219.30K |
| Change in Net Operating Assets | -264.10K | -13.70K | 393.40K | 252.80K | 278.30K |
| Cash from Operations | -1.83M | -1.75M | -1.59M | -1.45M | -1.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -150.00K | 150.00K | -- | -- |
| Other Investing Activities | 0.00 | 150.00K | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 150.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 524.70K | 5.30M | 50.60K | 0.00 | 3.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 524.70K | 5.30M | 50.60K | 0.00 | 3.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.31M | 3.55M | -1.38M | -1.45M | 1.92M |